Diploma surged on Thursday after lifting its full-year organic growth target following a "strong" performance in the third quarter.
Source: Sharecast
In a very brief trading update for the nine months to 30 June, the company upped its organic growth target for the year to 10% from 8%.
Diploma highlighted year-to-date organic growth of 10%, with a continuation of the positive trends seen in the first half.
It also noted reported revenue growth of 12% YTD, with 4% from acquisitions, partly offset by FX.
The company said it invested around £39m in two "quality" acquisitions: Haagensen and Alpha Laboratories. The former adds to M-Seals' capability in Denmark, while the latter marks Diploma’s entry into the UK In Vitro Diagnostics market.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
